Form 4 for MRNA Moderna
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001127602-23-018126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-07 | 2023-06-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | — | +4,562 | 4,837 | +1,659% | — |
| D | 2023-06-07 | 2023-06-06 | MRNA | Garay Arpa | Chief Commercial Off | S - Sale+OE | $125.75 | -2,290 | 2,547 | -47% | -$288.0K |
| D | 2023-06-07 | 2023-06-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | $0.00 | -4,562 | 13.7K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-05 | M | A | 4,562 | — | 4,837 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Includes 275 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on May 31, 2023. |
| 2 | Common | Common Stock | 2023-06-06 | S | D | 2,290 | $125.75 | 2,547 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-06-05 | M | D | 4,562 | $0.00 | 13,686 | D | — · — to — | 4,562 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on June 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |